CDT Equity Inc. Files 8-K on Security Holder Rights
Ticker: CDTTW · Form: 8-K · Filed: Oct 9, 2025 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Cdt Equity Inc. (CDTTW) |
| Form Type | 8-K |
| Filed Date | Oct 9, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, rights-amendment, filing
TL;DR
CDT Equity Inc. filed an 8-K, watch for changes to security holder rights and bylaws.
AI Summary
CDT Equity Inc. filed an 8-K on October 9, 2025, reporting events as of October 8, 2025. The filing indicates material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws. The company, formerly known as Conduit Pharmaceuticals Inc. and Murphy Canyon Acquisition Corp., is based in Naples, Florida, and operates in the pharmaceutical preparations sector.
Why It Matters
This 8-K filing signals potential changes in the rights of CDT Equity Inc.'s security holders and amendments to its corporate governance documents, which could impact investors.
Risk Assessment
Risk Level: medium — Filings related to material modifications of security holder rights and amendments to corporate documents can indicate significant changes that may affect stock value and investor protections.
Key Players & Entities
- CDT Equity Inc. (company) — Registrant
- Conduit Pharmaceuticals Inc. (company) — Former company name
- Murphy Canyon Acquisition Corp. (company) — Former company name
- October 8, 2025 (date) — Earliest event reported date
- October 9, 2025 (date) — Filing date
FAQ
What specific material modifications to the rights of security holders are being reported by CDT Equity Inc.?
The filing indicates 'Material Modifications to Rights of Security Holders' as an item information, but the specific details of these modifications are not provided in the excerpt.
What amendments are being made to CDT Equity Inc.'s articles of incorporation or bylaws?
The filing lists 'Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year' as an item information, but the specific amendments are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 8, 2025.
What is CDT Equity Inc.'s former company name?
CDT Equity Inc. was formerly known as Conduit Pharmaceuticals Inc. and Murphy Canyon Acquisition Corp.
What is the business address of CDT Equity Inc.?
The business address of CDT Equity Inc. is 4851 Tamiami Trail North, Suite 200, Naples, FL 34103.
Filing Stats: 1,126 words · 5 min read · ~4 pages · Grade level 11 · Accepted 2025-10-09 08:15:40
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share CDT The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 49KB
- ex3-1.htm (EX-3.1) — 15KB
- ex99-1.htm (EX-99.1) — 12KB
- 0001493152-25-017533.txt ( ) — 295KB
- cdt-20251008.xsd (EX-101.SCH) — 4KB
- cdt-20251008_def.xml (EX-101.DEF) — 26KB
- cdt-20251008_lab.xml (EX-101.LAB) — 36KB
- cdt-20251008_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CDT EQUITY INC. October 9, 2025 By: /s/ Andrew Regan Name: Andrew Regan Title: Chief Executive Officer